Guido Bellezza
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 46
- Lung Cancer Research Studies 12
- HER2/EGFR in Cancer Research 9
- Cancer Immunotherapy and Biomarkers 8
- Co-authors
- Angelo SidoniAntonio CavaliereE BucciarelliLucio CrinòVienna LudoviniRita ChiariMassimo ScheibelMaurizio Tonato
- Journals
- Oncotarget (6 papers)The Breast (5 papers)Lung Cancer (5 papers)Journal of Clinical Oncology (4 papers)Journal of Thoracic Oncology (3 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Guido Bellezza
120 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 113
- Cancer Research 581
- Oncology 1.0k
- Biological Psychiatry 78
- Pulmonary and Respiratory Medicine 942
- Pathology and Forensic Medicine 294
Countries citing papers authored by Guido Bellezza
This map shows the geographic impact of Guido Bellezza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Bellezza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Bellezza more than expected).
Fields of papers citing papers by Guido Bellezza
This network shows the impact of papers produced by Guido Bellezza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Bellezza. The network helps show where Guido Bellezza may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guido Bellezza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2021 | 3 | |
| 7 | 2020 | 22 | |
| 8 | 2018 | 0 | |
| 9 | 2018 | 7 | |
| 10 | 2018 | 22 | |
| 11 | 2015 | 52 | |
| 12 | Identification of Targetable Driver Mutations In Molecularly Selected Never Smoker Lung Adenocarcinomas | 2013 | 1 |
| 13 | 2010 | 46 | |
| 14 | 2008 | 16 | |
| 15 | Detection of HER-2/neu (c-erbB-2) overexpression and amplification in breast carcinomas with ambiguous immunohistochemical results. A further contribution to defining the role of fluorescent in situ hybridization. | 2006 | 14 |
| 16 | 2004 | 3 | |
| 17 | 2004 | 311 | |
| 18 | 2003 | 106 | |
| 19 | 2003 | 10 | |
| 20 | [Chemical and immunologic relationships in the Actinomycetales. 3. Changes in the antigenic constitution of a strain of Streptomyces aureofaciens after mutation]. | 1968 | 1 |
About Guido Bellezza
Guido Bellezza is a scholar working on Microbiology, Oncology, Biological Psychiatry, Pulmonary and Respiratory Medicine and Cancer Research, having authored 124 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (31 papers), Lung Cancer Research Studies (12 papers), Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (9 papers), HER2/EGFR in Cancer Research (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Cancer Genomics and Diagnostics (7 papers) and Lung Cancer Diagnosis and Treatment (7 papers). The work is most often cited by research in Cancer Research (581 citations), Oncology (1.0k citations), Biological Psychiatry (78 citations), Pulmonary and Respiratory Medicine (942 citations) and Pathology and Forensic Medicine (294 citations). Guido Bellezza has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Angelo Sidoni, Antonio Cavaliere, E Bucciarelli, Lucio Crinò, Vienna Ludovini, Rita Chiari, Massimo Scheibel, Maurizio Tonato, Giulio Metro and Rachele Del Sordo. Their work appears in journals such as Oncotarget, The Breast, Lung Cancer, Journal of Clinical Oncology and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.